Nexus Pharmaceuticals, LLC v. Hikma Pharmaceuticals USA Inc.
1:25-cv-00018
Overview
Parties
Defendant
Hikma Pharmaceuticals PLC NPE (Individual / Inventor)
Represented By
0 Attorneys ListedHikma Pharmaceuticals USA Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Nexus Pharmaceuticals, LLC Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger
Richards, Layton & Finger, 920 North King Street
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11464752
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
|
Filed: 2021-07-21
Issued: 2022-10-11
|
Active (14.7 yrs remaining)
Expires: 2041-07-21
|
|
|
US11426369
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
|
Filed: 2021-12-20
Issued: 2022-08-30
|
Active (15.1 yrs remaining)
Expires: 2041-12-20
|
|
|
US11571398
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
|
Filed: 2022-09-12
Issued: 2023-02-07
|
Active (15.8 yrs remaining)
Expires: 2042-09-12
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
0
Granted
0
Denied
0
Pending / Review
5
Motions by Category
Key Dispositive Motions & Rulings